Chongqing Lummy Pharmaceutical Co.,Ltd (China)

Chongqing Lummy Pharmaceutical Co., Ltd is a high-tech pharmaceutical company located in Chongqing. The company was established in 2011 and has since been recognized as a "National Biotechnology Industry Base Leading Enterprise" and a "National Torch Plan Key High-tech Enterprise". In 2012, it was also recognized as a "National Innovative (Pilot) Enterprise", a "Chinese Pharmaceutical Research and Development Product Line Industrial Enterprise", an "Innovative Enterprise in Chongqing", a "Chongqing Technology Innovation Demonstration Enterprise", and a "Chongqing Intellectual Property Pilot Unit". The company has been rated as an AAA credit enterprise. Its trademark "Lummy" has been recognized as a "Famous Trademark in Chongqing", and its various products have been awarded as "Chongqing High-tech Products", "Chongqing Key New Products", "Chongqing Famous Brand Products", and "Chongqing Well-known Products". The company has strong research and development capabilities, with two research and development platforms, the "Chongqing Lummy Pharmaceutical Technology Center" and the "Lummy-Sichuan University Joint Laboratory". It also has a "Municipal Enterprise Technology Center" in Chongqing and a "Chongqing Drug Quality Control Engineering Technology Research Center" jointly established with the US-listed company American Sajin Pharmaceutical. The company is one of the earliest enterprises in China to obtain GMP and GSP certifications. It has production bases in Chongqing Tea Garden New Area, Chongqing Changshou Chemical Industrial Park, Hunan Changsha Liuyang, Yiyang, and Chengdu High-tech Zone. The company has a rich product portfolio, including all types of injectables such as large and small volume injections, powder injections, and lyophilized powder injections, making it one of the most comprehensive pharmaceutical production companies in China for injectable dosage forms.